Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042217 · ClinicalTrials.gov registry record · NA
Transcranial Direct Current Stimulation for Depression
A NA study of Unipolar Depression, sponsored by Soterix Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07042217: Recruiting NA study of Unipolar Depression, sponsored by Soterix Medical.
NCT07042217 is a NA study of Unipolar Depression that is actively recruiting participants, run by Soterix Medical. The registered enrollment target is 25 participants, below the 82-participant average among 8 other Unipolar Depression trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042217, a NA study of Unipolar Depression, is actively recruiting participants, sponsored by Soterix Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
Primary Outcome
Change in HDRS score from Baseline
Conditions Studied
Interventions
- DEVICE transcranial direct current stimulation (tDCS) and mindfulness instruction
- DEVICE Sham tDCS and Mindfulness
Study Locations (1)
New Jersey
- Soterix Medical, Inc. - Woodbridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT07042217 shows while recruiting
NCT07042217 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 82-participant average among 8 other Unipolar Depression trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Unipolar Depression appearing as the primary indexed condition, and to 2 interventions - of which transcranial direct current stimulation (tDCS) and mindfulness instruction is the first listed.
NCT07042217 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07042217 about?
NCT07042217 is a clinical study titled "Transcranial Direct Current Stimulation for Depression". This study will test the efficacy of transcranial direct current stimulation (tDCS) combined with mindfulness, remotely-delivered using a telemedicine protocol in 25 adults with unipolar depression.
What is the current status of trial NCT07042217?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-07-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07042217 study?
This clinical trial studies the following conditions: Unipolar Depression.
What interventions are being tested in trial NCT07042217?
The interventions under investigation include: transcranial direct current stimulation (tDCS) and mindfulness instruction (DEVICE), Sham tDCS and Mindfulness (DEVICE).
Who is sponsoring clinical trial NCT07042217?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07042217 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unipolar Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07042217's enrollment target sits among peer trials
25 8th of 8 higher than 1 of 8 other Unipolar Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Unipolar Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Tao Calligraphy Meditation and Energized Water on Depression
RECRUITING · NA
-
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
RECRUITING · Phase 4
-
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
RECRUITING · Phase 2
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
COMPLETED · Phase 3
-
Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
COMPLETED · Phase 3
-
Home-administered tDCS for Treatment of Depression
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI